Merus NV (MRUS)
45.04
+0.11
(+0.24%)
USD |
NASDAQ |
Apr 26, 16:00
45.07
+0.03
(+0.07%)
After-Hours: 20:00
Merus Enterprise Value: 2.273B for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 2.273B |
| April 25, 2024 | 2.266B |
| April 24, 2024 | 2.094B |
| April 23, 2024 | 2.027B |
| April 22, 2024 | 2.005B |
| April 19, 2024 | 1.968B |
| April 18, 2024 | 2.006B |
| April 17, 2024 | 2.040B |
| April 16, 2024 | 1.997B |
| April 15, 2024 | 2.053B |
| April 12, 2024 | 2.087B |
| April 11, 2024 | 2.159B |
| April 10, 2024 | 2.080B |
| April 09, 2024 | 2.145B |
| April 08, 2024 | 2.213B |
| April 05, 2024 | 2.253B |
| April 04, 2024 | 2.244B |
| April 03, 2024 | 2.246B |
| April 02, 2024 | 2.282B |
| April 01, 2024 | 2.273B |
| March 28, 2024 | 2.272B |
| March 27, 2024 | 2.256B |
| March 26, 2024 | 2.265B |
| March 25, 2024 | 2.257B |
| March 22, 2024 | 2.325B |
| Date | Value |
|---|---|
| March 21, 2024 | 2.378B |
| March 20, 2024 | 2.291B |
| March 19, 2024 | 2.271B |
| March 18, 2024 | 2.231B |
| March 15, 2024 | 2.206B |
| March 14, 2024 | 2.247B |
| March 13, 2024 | 2.289B |
| March 12, 2024 | 2.326B |
| March 11, 2024 | 2.429B |
| March 08, 2024 | 2.361B |
| March 07, 2024 | 2.394B |
| March 06, 2024 | 2.488B |
| March 05, 2024 | 2.538B |
| March 04, 2024 | 2.541B |
| March 01, 2024 | 2.645B |
| February 29, 2024 | 2.452B |
| February 28, 2024 | 2.464B |
| February 27, 2024 | 2.478B |
| February 26, 2024 | 2.401B |
| February 23, 2024 | 2.392B |
| February 22, 2024 | 2.382B |
| February 21, 2024 | 2.248B |
| February 20, 2024 | 2.243B |
| February 16, 2024 | 2.307B |
| February 15, 2024 | 2.159B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
89.13M
Minimum
Mar 18 2020
2.645B
Maximum
Mar 01 2024
612.58M
Average
523.10M
Median
Mar 28 2023
Enterprise Value Benchmarks
| argenx SE | 18.98B |
| uniQure NV | -299.44M |
| ProQR Therapeutics NV | 31.11M |
| Pharming Group | 584.99M |
| Pharvaris NV | 824.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.15M |
| Revenue (Quarterly) | 8.939M |
| Total Expenses (Quarterly) | 56.48M |
| EPS Diluted (Quarterly) | -1.09 |
| Profit Margin (Quarterly) | -672.9% |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -6.398 |